Objective: To evaluate the detectability of herpes simplex virus type 1 and 2 (HSV-1, 2) antigens in the esophageal mucosa in esophageal cancer. Methods: A cross-sectional pilot study with a control group was conducted from December 2022 to May 2023. The patients were divided into two groups: the main group with verified esophageal cancer and the control group without esophageal cancer based on the histological report. Diagnosis using fibroesophagogastroscopy (FEGS), histological analysis, and indirect immunofluorescence reaction (iIFR) was accomplished according to indications at the outpatient center of the endoscopic department of the Multidisciplinary Medical Center, Astana. Descriptive statistics and nonparametric methods were used to analyze the data. Result: A total of 30 patients were recruited in the study, with 15 patients in the main group and 15 patients in the control group. HSV-1 and HSV-2 antigens were detected in the 13 cases (86.7%) during the study of biomaterial from patients with confirmed esophageal cancer in the main group and only in one case (6.8%) in the control group (95% CI 7.35 - 1126.9%, p=0.001). The presence of lymphocytic infiltration was detected in 13 cases (86.7%) in the main group and in 5 cases (33.3%) in the control group (95% CI 2.07 - 81.48%, p = 0.008). The process of keratinization was identified in HSV-1,2 antigens positive cases in the main group in 5 cases (35.7%) G1, in 5 cases (35.7%) G2, and in 3 cases (21.4 %) G3 (95% CI 1.66 - 656.23%, p=0.002). Conclusion: Overall, the local activity of herpesvirus infection to a certain extent influences the malignant potential of tumor cells and the resistance of surrounding healthy tissues. A large-scale study is still needed to confirm these results. The present pilot study provided an overview of a possible method for detecting HSV-1,2 activity in malignant tissue from esophageal cancer.
Azhken, B., Apsalyamov, V., Baryshev, B., Grigorevsky, V., & Shelestyuk, A. (2024). Indirect Immunofluorescence Test for Detecting HSV-1, 2 in Patients with Esophageal Cancer: A Pilot Cross-Sectional Survey in Kazakhstan. Asian Pacific Journal of Cancer Prevention, 25(10), 3559-3565. doi: 10.31557/APJCP.2024.25.10.3559
MLA
Bakhtiyar Azhken; Valiy Apsalyamov; Boris Baryshev; Vladimir Grigorevsky; Alina Shelestyuk. "Indirect Immunofluorescence Test for Detecting HSV-1, 2 in Patients with Esophageal Cancer: A Pilot Cross-Sectional Survey in Kazakhstan". Asian Pacific Journal of Cancer Prevention, 25, 10, 2024, 3559-3565. doi: 10.31557/APJCP.2024.25.10.3559
HARVARD
Azhken, B., Apsalyamov, V., Baryshev, B., Grigorevsky, V., Shelestyuk, A. (2024). 'Indirect Immunofluorescence Test for Detecting HSV-1, 2 in Patients with Esophageal Cancer: A Pilot Cross-Sectional Survey in Kazakhstan', Asian Pacific Journal of Cancer Prevention, 25(10), pp. 3559-3565. doi: 10.31557/APJCP.2024.25.10.3559
VANCOUVER
Azhken, B., Apsalyamov, V., Baryshev, B., Grigorevsky, V., Shelestyuk, A. Indirect Immunofluorescence Test for Detecting HSV-1, 2 in Patients with Esophageal Cancer: A Pilot Cross-Sectional Survey in Kazakhstan. Asian Pacific Journal of Cancer Prevention, 2024; 25(10): 3559-3565. doi: 10.31557/APJCP.2024.25.10.3559
)